Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Ibuprofen and Diphenhydramine MR Tablets
NCT05729555Phase 1Unknown
- Sponsor
- Overseas Pharmaceuticals
- Start
- Apr 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen and diphenhydramine in pain and Insomnia (2 arms), sponsored by Overseas Pharmaceuticals. Primary endpoints: Area under the curve from time zero to the last quantifiable concentration at 48 hours, Area under the curve from time zero to infinity at 48 hours and 1 more. Status: unknown.
02
Drugs
ibuprofendiphenhydramine
03
Conditions
painInsomnia
Beyond the preview
Go deeper on NCT05729555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729555.